← back to search

Weiya Xia

National Yang Ming Chiao Tung University · TW
Area of research
Molecular Biology · Genetics
Research interest
Research focused on Cancer research and PD-L1, with related work in Glycosylation, Breast cancer, Immune system. Notable publications include 'Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity', 'PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis', and 'STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion'.
h-index
citations
4,003
works
15
NIH funding
primary concept
email

Recent publications

Targeting ALK averts ribonuclease 1-induced immunosuppression and enhances antitumor immunity in hepatocellular carcinoma
Nature Communications 2024cited by 19position: middledoi
Inhibition of Galectin-9 sensitizes tumors to anthracycline treatment via inducing antitumor immunity
International Journal of Biological Sciences 2023cited by 9position: middledoi
Erratum to ‘Ribonuclease 7-driven activation of ROS1 is a potential therapeutic target in hepatocellular carcinoma’ [J Hepatol 2021 (907-918)]
Journal of Hepatology 2022cited by 1position: middledoi
Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiation
Nature Communications 2021cited by 31position: middledoi
PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis
Nature Cell Biology 2020cited by 993position: middledoi
Ribonuclease 7-driven activation of ROS1 is a potential therapeutic target in hepatocellular carcinoma
Journal of Hepatology 2020cited by 31position: middledoi
Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy
Cancer Cell 2019cited by 408position: middledoi
IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion
Journal of Clinical Investigation 2019cited by 380position: middledoi
MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1
Gastroenterology 2019cited by 186position: middledoi
CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer
Nature Communications 2019cited by 99position: middledoi
STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion
Nature Communications 2018cited by 427position: middledoi
Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung Cancer
Cancer Cell 2018cited by 71position: middledoi
JAK2-binding long noncoding RNA promotes breast cancer brain metastasis
Journal of Clinical Investigation 2017cited by 230position: middledoi
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
Nature Communications 2016cited by 1,099position: middledoi
Expression of metastasis suppressor BRMS1 in breast cancer cells results in a marked delay in cellular adhesion to matrix
Molecular Carcinogenesis 2013cited by 19position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mien‐Chie Hung · Institute of Biomedical Science11 papers (2013–2024)Jennifer L. Hsu · The University of Texas MD Anderson Cancer Center7 papers (2016–2022)Jung-Mao Hsu · University of Houston7 papers (2016–2023)Li-Chuan Chan · University of Houston5 papers (2016–2023)Heng‐Huan Lee · University of Houston5 papers (2016–2024)Shao‐Chun Wang · University of Kentucky4 papers (2019–2024)Chia‐Wei Li · National Taiwan University4 papers (2016–2020)Ying‐Nai Wang · The University of Texas MD Anderson Cancer Center4 papers (2019–2024)Meisi Yan · Harbin Medical University3 papers (2019–2022)Dihua Yu · The University of Texas MD Anderson Cancer Center3 papers (2016–2024)Yufan Qiu · Ministry of Education of the People's Republic of China3 papers (2020–2024)Chenhao Zhou · Fudan University3 papers (2020–2024) · 3 papers (2020–2022) · 2 papers (2020–2023)Jun Yao · Anhui Medical University2 papers (2016–2017)Zhengyu Zha · Fudan University2 papers (2020–2022)Gabriel N. Hortobágyi · The University of Texas MD Anderson Cancer Center2 papers (2016–2019)Ning Ren · Zhejiang Chinese Medical University2 papers (2020–2024) · 2 papers (2022–2023)Kay‐Hooi Khoo · National Taiwan University2 papers (2016–2018)